U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218367) titled 'Phase I Trial of pH Resections of GBM at VA' on Oct. 15.
Brief Summary: Glioblastoma is an infiltrating tumor that is difficult to visualize in surgery and on standard images. A special pH (acid-base) related magnetic resonance imaging (MRI) has been developed to better see infiltrating tumor. In this safety study, the investigators will carry out increased levels of pH based resections of infiltrating tumor to assess the tolerability in VA populations.
Study Start Date: Feb. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Glioblastoma
Intervention:
PROCEDURE: pH MRI based resection of GBM
This will require a chemical exchange...